Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight Medical Products, Eclipse Resources, and Aircastle with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, March 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), Hancock Holding Company (NASDAQ:HBHC), MKS Instruments, Inc. (NASDAQ:MKSI), Second Sight Medical Products, Inc. (NASDAQ:EYES), Eclipse Resources Corporation (NYSE:ECR), and Aircastle Limited (NYSE:AYR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ANTH DOWNLOAD: http://Fundamental-Markets.com/register/?so=ANTH
HBHC DOWNLOAD: http://Fundamental-Markets.com/register/?so=HBHC
MKSI DOWNLOAD: http://Fundamental-Markets.com/register/?so=MKSI
EYES DOWNLOAD: http://Fundamental-Markets.com/register/?so=EYES
ECR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ECR
AYR DOWNLOAD: http://Fundamental-Markets.com/register/?so=AYR

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), Hancock Holding Company (NASDAQ:HBHC), MKS Instruments, Inc. (NASDAQ:MKSI), Second Sight Medical Products, Inc. (NASDAQ:EYES), Eclipse Resources Corporation (NYSE:ECR), and Aircastle Limited (NYSE:AYR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 16th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ANTHERA PHARMACEUTICALS, INC. (ANTH) REPORT OVERVIEW

Anthera Pharmaceuticals' Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Anthera Pharmaceuticals reported revenue of $0.00MM vs $0.15MM and basic earnings per share -$2.86 vs -$12.87. Anthera Pharmaceuticals is expected to report earnings on May 9th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$2.03. The estimated EPS forecast for the next fiscal year is -$1.42 and is expected to report on March 4th, 2019.

To read the full Anthera Pharmaceuticals, Inc. (ANTH) report, download it here: http://Fundamental-Markets.com/register/?so=ANTH

-----------------------------------------

HANCOCK HOLDING COMPANY (HBHC) REPORT OVERVIEW

Hancock Holding's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Hancock Holding reported interest income of $239.17MM vs $185.87MM (up 28.68%) and basic earnings per share $0.64 vs $0.64 (unchanged). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Hancock Holding reported interest income of $900.58MM vs $732.17MM (up 23.00%) and basic earnings per share $2.49 vs $1.87 (up 33.16%). Hancock Holding is expected to report earnings on April 17th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.63. The estimated EPS forecast for the next fiscal year is $4.20 and is expected to report on January 16th, 2019.

To read the full Hancock Holding Company (HBHC) report, download it here: http://Fundamental-Markets.com/register/?so=HBHC

-----------------------------------------

MKS INSTRUMENTS, INC. (MKSI) REPORT OVERVIEW

MKS Instruments' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, MKS Instruments reported revenue of $511.80MM vs $405.14MM (up 26.33%) and basic earnings per share $1.43 vs $0.85 (up 68.24%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MKS Instruments reported revenue of $1,915.98MM vs $1,295.34MM (up 47.91%) and basic earnings per share $6.26 vs $1.96 (up 219.39%). MKS Instruments is expected to report earnings on April 25th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.27. The estimated EPS forecast for the next fiscal year is $8.62 and is expected to report on January 30th, 2019.

To read the full MKS Instruments, Inc. (MKSI) report, download it here: http://Fundamental-Markets.com/register/?so=MKSI

-----------------------------------------

SECOND SIGHT MEDICAL PRODUCTS, INC. (EYES) REPORT OVERVIEW

Second Sight Medical Products' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Second Sight Medical Products reported revenue of $1.61MM vs $1.18MM (up 36.44%) and basic earnings per share -$0.12 vs -$0.20. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Second Sight Medical Products reported revenue of $3.99MM vs $8.95MM (down 55.47%) and basic earnings per share -$0.84 vs -$0.56. Second Sight Medical Products is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.18. The estimated EPS forecast for the next fiscal year is -$0.51 and is expected to report on March 6th, 2019.

To read the full Second Sight Medical Products, Inc. (EYES) report, download it here: http://Fundamental-Markets.com/register/?so=EYES

-----------------------------------------

ECLIPSE RESOURCES CORPORATION (ECR) REPORT OVERVIEW

Eclipse Resources' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Eclipse Resources reported revenue of $104.06MM vs $83.88MM (up 24.05%) and basic earnings per share -$0.05 vs -$0.23. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Eclipse Resources reported revenue of $383.66MM vs $235.03MM (up 63.24%) and basic earnings per share $0.03 vs -$0.86. Eclipse Resources is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.01.

To read the full Eclipse Resources Corporation (ECR) report, download it here: http://Fundamental-Markets.com/register/?so=ECR

-----------------------------------------

AIRCASTLE LIMITED (AYR) REPORT OVERVIEW

Aircastle's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Aircastle reported revenue of $177.40MM vs $204.65MM (down 13.32%) and basic earnings per share $0.70 vs $0.86 (down 18.60%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Aircastle reported revenue of $796.62MM vs $772.96MM (up 3.06%) and basic earnings per share $1.88 vs $1.92 (down 2.08%). Aircastle is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.55. The estimated EPS forecast for the next fiscal year is $2.32 and is expected to report on February 12th, 2019.

To read the full Aircastle Limited (AYR) report, download it here: http://Fundamental-Markets.com/register/?so=AYR

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.